Status:

COMPLETED

Telomere Disclosure and Impact on Psychological Distress and Health Behaviors

Lead Sponsor:

University of California, San Francisco

Conditions:

Telomere Length, Mean Leukocyte

Eligibility:

FEMALE

50-65 years

Phase:

NA

Brief Summary

There is now a critical mass of data linking health to telomere length, and blood telomere length is starting to become a commercially available measure, with several companies either offering or plan...

Detailed Description

Background and Significance: Briefly sketch the scientific background leading to the present proposal, critically evaluate existing knowledge (with references), and specifically identify the gaps the ...

Eligibility Criteria

Inclusion

  • 50-65 year old women

Exclusion

  • Women were excluded from the study if they had a major medical condition (cancer diagnosis in the past five years, cancer treatment within the past ten years, diagnosis of an autoimmune disorder) or reported currently smoking.

Key Trial Info

Start Date :

April 4 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 15 2011

Estimated Enrollment :

263 Patients enrolled

Trial Details

Trial ID

NCT04104386

Start Date

April 4 2010

End Date

November 15 2011

Last Update

September 26 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.